The Current Ratio as of December 2024 (TTM) for RedHill Biopharma Ltd. (RDHL) is 0.84

According to RedHill Biopharma Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 0.84. This represents a change of 20.50% compared to the average of 0.70 of the last 4 quarters.

RedHill Biopharma Ltd. (RDHL) Historical Current Ratio (quarterly & annually)

How has RDHL Current Ratio performed in the past?

The mean historical Current Ratio of RedHill Biopharma Ltd. over the last ten years is 5.69. The current 0.84 Current Ratio has changed 1.37% with respect to the historical average. Over the past ten years (40 quarters), RDHL's Current Ratio was at its highest in in the March 2014 quarter at 31.74. The Current Ratio was at its lowest in in the September 2022 quarter at 0.43.

RedHill Biopharma Ltd. (RDHL) Current Ratio by Quarter and Year

Discovering the peaks and valleys of RedHill Biopharma Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

RedHill Biopharma Ltd. (RDHL) Average Current Ratio

How has RDHL Current Ratio performed in the past?

The current Current Ratio of RedHill Biopharma Ltd. (RDHL) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

RedHill Biopharma Ltd. (RDHL) Current Ratio vs. Peers

How is RDHL’s Current Ratio compared to its peers?

RedHill Biopharma Ltd.’s Current Ratio is less than Organogenesis Holdings Inc. (3.09), less than Lifecore Biomedical, Inc. (1.83), less than Taro Pharmaceutical Industries Ltd. (3.61), less than Collegium Pharmaceutical, Inc. (0.97), less than Aquestive Therapeutics, Inc. (6.37), less than Evoke Pharma, Inc. (1.44), greater than Adamis Pharmaceuticals Corporation (0.58), less than Guardion Health Sciences, Inc. (16.67), less than AcelRx Pharmaceuticals, Inc. (4.42), less than Petros Pharmaceuticals, Inc. (0.85), less than Cumberland Pharmaceuticals Inc. (1.13), greater than Agile Therapeutics, Inc. (0.55), greater than PainReform Ltd. (0.61), greater than China Pharma Holdings, Inc. (0.79), less than Halo Collective Inc. (1.40), less than Alimera Sciences, Inc. (2.79), less than China SXT Pharmaceuticals, Inc. (1.60), less than Alpha Teknova, Inc. (4.73), greater than Cyclo Therapeutics, Inc. (0.17),

Build a custom stock screener for RedHill Biopharma Ltd. (RDHL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RedHill Biopharma Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

RedHill Biopharma Ltd. (RDHL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like RedHill Biopharma Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.